Clearmind Medicine to Delist from CSE, Focus on Nasdaq
Ticker: CMND · Form: 6-K · Filed: Mar 13, 2024 · CIK: 1892500
Sentiment: neutral
Topics: delisting, exchange-transition, sec-filing
Related Tickers: CMND
TL;DR
Clearmind ditching CSE for Nasdaq focus. Shares last trade March 15th.
AI Summary
Clearmind Medicine Inc. announced on March 13, 2024, that it has received approval for the voluntary delisting of its common shares from the Canadian Securities Exchange (CSE). The delisting is expected to become effective on March 18, 2024, with the last trading day on the CSE being March 15, 2024. The company's shares will continue to trade on the Nasdaq Capital Market under the ticker symbol "CMND".
Why It Matters
This move simplifies the company's trading structure, potentially reducing costs and administrative burden by consolidating its listing on the Nasdaq Capital Market.
Risk Assessment
Risk Level: low — The filing is a routine announcement of a voluntary delisting from one exchange to focus on another, with no immediate financial or operational risks indicated.
Key Players & Entities
- Clearmind Medicine Inc. (company) — Registrant
- Canadian Securities Exchange (CSE) (company) — Exchange for delisting
- Nasdaq Capital Market (company) — Exchange for continued trading
- March 13, 2024 (date) — Date of press release
- March 18, 2024 (date) — Effective date of delisting
- March 15, 2024 (date) — Last trading day on CSE
- CMND (ticker) — Nasdaq ticker symbol
FAQ
What is the primary reason for Clearmind Medicine's voluntary delisting from the CSE?
The company is seeking to simplify its trading structure and focus its listing on the Nasdaq Capital Market.
When will Clearmind Medicine's common shares cease trading on the CSE?
The last day of trading on the CSE is expected to be March 15, 2024.
What is the effective date of the voluntary delisting from the CSE?
The delisting is expected to become effective on March 18, 2024.
Will Clearmind Medicine's shares continue to be publicly traded?
Yes, the company's common shares will continue to trade on the Nasdaq Capital Market under the ticker symbol "CMND".
What form is this filing?
This is a Form 6-K, Report of Foreign Private Issuer.
Filing Stats: 274 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-03-13 16:01:03
Filing Documents
- ea0201711-6k_clearmind.htm (6-K) — 11KB
- ea020171102ex99-1_clearmind.htm (EX-99.1) — 11KB
- 0001213900-24-022157.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Clearmind Medicine, Inc. (Registrant) Date: March 13, 2024 By: /s/ Adi Zuloff-Shani Name: Adi Zuloff-Shani Title: Chief Executive Officer 2